A critical advance in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This vital tumor suppressor protein is frequently disabled in several types of tumors, leading https://cruxbookmarks.com/story22036989/mini-antibodies-restore-p53-the-promising-pathway-for-cancer-treatment